Ornithine decarboxylase (ODC), the target enzyme of D,L-␣-difluoromethylornithine (DFMO), was investigated in four DFMO-tolerant Trypanosoma brucei rhodesiense isolates from East Africa and two DFMOsusceptible T. b. gambiense isolates from West Africa. Neither drug uptake nor inhibition of ODC activity by DFMO in cellular extracts differed in the two trypanosome subspecies. However, the specific ODC activity of the cellular extracts was three times as high in T. b. rhodesiense isolates as in T. b. gambiense isolates. Furthermore, a significant difference in the turnover rate of ODC was observed. The time required to induce a 50% reduction of T. b. rhodesiense ODC activity under cycloheximide pressure (tentative half-life) was about 4.3 h, whereas that required for T. b. gambiense ODC was longer than 18 h. We concluded that the higher specific ODC activity and faster enzyme turnover contributed to a substantial degree to the DFMO tolerance observed in the East African T. b. rhodesiense isolates.
D,L-␣-Difluoromethylornithine (DFMO; Ornidyl) is one of only two drugs available for the treatment of late-stage sleeping sickness in Africa. DFMO is used mainly in West Africa to cure relapses after failure of melarsoprol (Arsobal) treatment (25) , and until now it has been the only alternative to melarsoprol. Only few clinical data are available concerning its efficacy against East African Trypanosoma brucei rhodesiense infections (5) , and these indicate the failure of DFMO treatment. Furthermore, only 35% of infections with T. b. rhodesiense isolates could be cured by DFMO in a rodent model (3, 4) . It was shown that Ugandan T. b. rhodesiense isolates and West African T. b. gambiense isolates respond very differently to DFMO in vitro (12) . While T. b. gambiense isolates were highly susceptible to DFMO, 32 Ugandan T. b. rhodesiense isolates were tolerant to the drug. Since DFMO has never been used in the area of isolation, the nonresponsiveness of these isolates to DFMO is based not on acquired resistance but on innate tolerance.
DFMO is an enzyme-activated, irreversible inhibitor of ornithine decarboxylase (ODC) (16) , one of the key enzymes in the polyamine biosynthetic pathway. As a derivative of ornithine, it serves as a substrate for ODC. Complete inhibition of ODC results in depletion of the polyamines putrescine and spermidine (1) , finally causing cessation of the proliferation of DFMO-exposed cells.
The mechanisms which mediate DFMO tolerance in T. b. rhodesiense and therefore cause problems in the DFMO treatment of rhodesiense sleeping sickness patients are not known. In this study, DFMO uptake, putrescine uptake, ODC specific activity, the effect of DFMO on ODC in cellular extracts, and the turnover rate of ODC were investigated to identify the characteristics expressed in the DFMO-tolerant phenotype found in T. b. rhodesiense isolates from East Africa.
MATERIALS AND METHODS
Trypanosomes. The T. b. rhodesiense STIB 859 and STIB 863 stocks studied were isolated from sleeping sickness patients from Uganda and propagated in rodents as described by Iten et al. (12) . T. b. rhodesiense STIB 878 was isolated from a patient in Uganda, T. b. rhodesiense STIB 879 was isolated from a patient in Mozambique, and both were stored as frozen stabilates in the KETRI stabilate bank (Kenya Trypanosomiasis Research Institute, Muguga, Kenya) (3). T. b. gambiense stocks (STIB 754B and DAL 1355R) were isolated from patients in the Ivory Coast (15) .
Cultivation. Bloodstream form trypanosomes were cultivated in minimum essential medium with Earle's salts (GIBCO/BRL no. 072-01100 P) supplemented with 25 mM HEPES, 1 g of additional glucose per liter, 2.2 g of NaHCO 3 per liter, and 10 ml of minimum essential medium nonessential amino acids (100ϫ; GIBCO/BRL no. 11140-035) per liter. The medium was further supplemented as described by Baltz et al. (6) , with 0.2 mM 2-mercaptoethanol, 2 mM Na-pyruvate, 0.1 mM hypoxanthine, and 0.016 mM thymidine. Heat-inactivated horse serum (15%) was added to the medium for T. b. rhodesiense cultures, and 15% normal human serum and 5% heat-inactivated fetal calf serum were added to the medium for T. b. gambiense cultures. Cultures were maintained at 37°C in a humidified atmosphere of 5% CO 2 in air.
Drug susceptibility assays. Trypanosome stocks were tested for susceptibility to DFMO in a long-term viability assay over a period of 10 days as previously described (13) , with minor modifications (12) .
The influence of putrescine on DFMO susceptibility was investigated by employing the [ 3 H]hypoxanthine incorporation assay as described by Brun and Kunz (8) [14] ) supplemented with D,L-␣- [3,4- 3 H]DFMO (10 Ci/ml, 22.7 Ci/mmol; New England Nuclear, Dupont, Regensdorf, Switzerland) and nonlabelled DFMO to a final concentration of 70 M. The cells were incubated for 60 min at 37°C in a humidified atmosphere of 5% CO 2 in air. One-milliliter aliquots were centrifuged through oil (90% dibutylphthalate-10% paraffin [vol/vol]) at 14,000 ϫ g for 15 s. Tubes were transferred to liquid nitrogen, and the tube tips with the pellet were cut off, placed in 5 ml of scintillation liquid (Ecoscint A; National Diagnostics, Atlanta, Ga.), and counted for 1 min each in a liquid scintillation counter (MR 300; Kontron Instruments, Zürich, Switzerland). Uptake was based on the total DFMO accumulated after 1 h (4). Measurement of [ 3 H]putrescine uptake was performed with trypanosomes preincubated with DFMO (12.7 M) for 16 h and with untreated trypanosomes. The cells were prepared as described above. [2,3- for determination of ODC and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) activity. After propagation of T. b. rhodesiense in Swiss ICR mice and of T. b. gambiense in Mastomys natalensis, parasites were isolated from blood as previously described (14), with the minor modification that DE53 cellulose was used instead of DE52 cellulose. Purified trypanosomes were suspended in lysis buffer (50 mM Na 2 HPO 4 -NaH 2 PO 4 , 0.1 mM EDTA, 2 mM dithiothreitol, 1 mg of aprotinin per ml, 0.1 mM phenylmethylsulfonyl fluoride, pH 7.4) and homogenized by freeze-thawing. After centrifugation at 10,000 ϫ g for 30 min at 10°C, the supernatant was stored in aliquots at Ϫ80°C. The ODC activity of cell extracts was determined as previously described (19) , and GAPDH activity was determined as described by Hamm et al. (11) .
[ 3 H]leucine incorporation into proteins. Trypanosomes were cultivated in the medium described above lacking leucine (GIBCO/BRL no. 041-01895). L- [4, H]leucine (120 to 190 Ci/mmol; Amersham, Rahn AG, Zürich, Switzerland) was added to log phase cultures at a final concentration of 0.5 Ci/ml. After 10 min of preincubation at 37°C, 50 g of cycloheximide per ml was added. At this concentration, cycloheximide did not show toxic effects on trypanosomes over the observation period of 24 h (unpublished observations). At various time points up to 24 h, 6-ml aliquots were filtered through GF/B filters (Whatman, Maidstone, England). Proteins were precipitated on the filter discs with 10% trichloroacetic acid and then washed with ice-cold 5% trichloroacetic acid. After drying, filters were washed with ice-cold 70% ethanol. Dried filter discs were processed as described above for DFMO uptake experiments.
Northern blot analysis. The ODC DNA probe was generated by PCR with primers based on the previously cloned ODC sequence from T. b. brucei (20) . A sense primer, 5Ј-CTGCAGCAACACTGAGATACAACGTGTGAGAGGCA-3Ј (amino acid positions 111 to 120), and an antisense primer, 5Ј-CT GCAGCAAGTGTGAAAGCTGAAGCAACGTAGTACC-3Ј (amino acid positions 297 to 306), were constructed. Both contained PstI restriction sites inserted at the 5Ј end for subcloning. One microgram of T. b. brucei STIB 920 genomic DNA was added to a reaction mixture containing 1ϫ PCR buffer (Boehringer Mannheim), 10% (vol/vol) dimethyl sulfoxide, each deoxynucleoside triphosphate at 200 M, 1 g of each oligonucleotide primer, and 2.5 U of Taq DNA polymerase in a volume of 100 l. The reaction mixture was incubated in a thermocycler at 95, 42, and 72°C for 1, 2, and 2 min, respectively, for 40 cycles. Both PCR bands were subcloned into the bluescript KSϩ (Stratagene) PstI site, and the sequences were confirmed.
Total RNA was isolated by employing the Trizol reagent (GIBCO/BRL no. 15596-026) in accordance with the product descriptions, and 20 g was electrophoresed on 1.5% formaldehyde gels and transferred onto Hybond Nϩ membranes. Filters were hybridized with a 32 P-labelled ODC probe (random prime kit; Boehringer Mannheim) at 42°C overnight. The blots were washed in 2ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.5% sodium dodecyl sulfate with increasing temperature to remove the nonspecifically bound probe. All blots were visualized by autoradiography.
RESULTS
Drug susceptibility. The DFMO susceptibilities of four East African T. b. rhodesiense isolates and two West African T. b. gambiense isolates were determined in the 10-day feeder layer viability assay ( Effect of putrescine on DFMO susceptibility. The effect of DFMO on the T. b. gambiense STIB 754B stock was abolished by putrescine (Fig. 1) . The same effect of putrescine on DFMO-treated T. b. gambiense DAL 1355R was observed (data not shown). When up to 0.1 mM putrescine was used, no effect on DFMO susceptibility could be measured, whereas at concentrations higher than 1 mM, the DFMO effect was fully reversed.
Enzyme activities. ODC and GAPDH activities were analyzed in crude extracts of the six isolates. The ODC specific activity for the T. b. rhodesiense isolates was in the range of 65 to 83 nmol of CO 2 /mg of protein/h (Table 1) , about three times the specific activity found in the T. b. gambiense isolates, which was in the range of 21 to 25 nmol of CO 2 /mg of protein/h. The GAPDH specific activity was in the range of 3.8 to 4.6 U/mg of Tentative half-life of ODC. The turnover rate of ODC in the different species was determined by measuring the decrease in ODC activity in cells in which protein synthesis had been inhibited by cycloheximide. [ 3 H]leucine incorporation was determined to confirm that protein synthesis had effectively been blocked (Fig. 2) (Fig. 3) .
DISCUSSION
The four East African T. b. rhodesiense isolates investigated in this study are representative samples of 32 isolates tolerant to DFMO (12) . The MICs for the four T. b. rhodesiense isolates were Ͼ100 M, which is higher than the DFMO levels in plasma or cerebrospinal fluid reached during treatment (the mean concentration in cerebrospinal fluid was 69 Ϯ 33 M [17] ). The MICs for the West African T. b. gambiense isolates were Ͻ20 M, which is below therapeutically achievable levels.
The only known target enzyme for DFMO is ODC (16) . rhodesiense isolates investigated in this study. Uptake studies performed on ice indicated that DFMO uptake is mediated by diffusion rather than by active transport. These observations confirm earlier findings by Bitonti et al. (7). The product of the reaction catalyzed by ODC is putrescine. Total inhibition of ODC by DFMO leads to depletion of the product putrescine (1). A possible way to bypass this blockage is the uptake of putrescine. However, in the six strains described here, putrescine uptake did not differ significantly between tolerant T. b. rhodesiense and susceptible T. b. gambiense (0.23 to 0.39 pmol/10 8 cells/h), which is different from earlier observations by Phillips and Wang (21), who found three-to fourfold increased putrescine uptake in DFMO-resistant procyclic (tsetse fly midgut-like) forms of T. b. brucei. The growthinhibitory effect of DFMO could only be reversed with putrescine concentrations higher than 1 mM. No reversion of DFMO-mediated growth inhibition was detected at a putrescine concentration of 0.1 mM, which is still 500 fold higher than the level achievable in blood (220 nM [9] ). Thus, under physiological conditions, blockage of ODC by DFMO is unlikely to be bypassed by increased putrescine uptake.
DFMO inhibited ODC in cellular extracts of all six of the isolates investigated to the same degree with IC 50 s of 24 to 35 M, indicating that the affinity of ODC to DFMO did not differ in the two trypanosome subspecies. However, the two subspecies differed with respect to ODC specific activity, which was about three times as high in T. b. rhodesiense extracts as in T. b. gambiense extracts. The higher specific activity was specific for ODC. As a control, GAPDH did not show higher specific activity in T. b. rhodesiense, which was in the range of previously published data (11) . The observed differences in ODC specific activity between the two subspecies may be significant regarding DFMO susceptibility of trypanosomes. The intracellular DFMO concentration after 1 h of DFMO exposure can be calculated as 54 to 71 M, considering an average cell volume of 30 fl and a DFMO uptake of 161.7 to 212.9 pmol/10 8 cells/h ( [20] ). However, the ODC mRNA of DFMO-susceptible T. b. gambiense was slightly shorter (2.2 kb), which indicates that structural differences may be present at the mRNA level which could have an impact on the regulation of the synthesis and/or degradation of the ODC mRNA.
Human cells have been shown to be little affected by DFMO, because they have a rapid turnover of ODC (half-life, 10 to 20 min [24] ) which is efficiently regulated and promptly responds to changing physiological conditions. A reduction of the ODC activity to 50% during cycloheximide treatment was reached within 4.2 to 4.4 h in DFMO-tolerant T. b. rhodesiense. This time interval was considerably shorter than that for T. b. gambiense, although it was still much longer than the half-life of mammalian ODC. Bacchi et al. (2) determined a 5-h ODC half-life in bloodstream forms of T. b. rhodesiense isolates in rodents by using a similar experimental approach. The key role of ODC in the polyamine pathway has been studied extensively in mammalian cells. The very short-lived mammalian ODC (24) is feedback regulated by polyamines. These polyamines, in excessive concentrations, also induce antizyme (18), a noncompetitive inhibitory protein which associates with the ODC, leading to inactivation and degradation of ODC by mammalian 26S proteasome (10) . The C-terminal PEST sequence, a proline (P)-, glutamic acid (E)-, serine (S)-, and threonine (T)-rich region (22) , is assumed to be involved in the fast degradation, and therefore in the short half-life, of ODC in mammalian cells. In contrast, trypanosomal (T. b. brucei) ODC does not contain PEST sequences contributing to a short half-life (7, 20) . However, the trypanosomatid Crithidia fasciculata has a short half-life of 30 min although it lacks the C-terminal degradation domain (23) . The mechanisms mediating the differences in the ODC turnover rates of T. b. rhodesiense and T. b. gambiense established in this study are not known and remain to be investigated.
The DFMO tolerance of East African T. b. rhodesiense isolates cannot be explained by only one mechanism. It appears, rather, that the sum of several factors leads to a DFMOtolerant phenotype. Two of the factors involved in DFMO tolerance could be identified: (i) higher specific ODC activity and (ii) a shorter tentative half-life of the enzyme. These findings indicate that the failure of DFMO treatment of East African T. b. rhodesiense infections is due to an innate lack of susceptibility of the parasite caused by alterations of the target enzyme and/or its regulation.
